NFE2L2 and multiple sclerosis: DMF is a highly lipophilic, mobile methyl ester, which, by activating the Nrf2 pathway, has been shown to reduce the relapse rate, slow the progression of multiple sclerosis [25,26,27], and alleviate chemical-induced colonic inflammatory damage [28,29].